Cubist Systematic Strategies’s Kymera Therapeutics KYMR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.18M | Buy |
+118,752
| New | +$5.18M | 0.02% | 467 |
|
|
2024
Q1 | – | Sell |
-95,580
| Closed | -$2.43M | – | 2547 |
|
|
2023
Q4 | $2.43M | Buy |
+95,580
| New | +$2.43M | 0.02% | 741 |
|
|
2023
Q1 | – | Sell |
-99,776
| Closed | -$2.49M | – | 3080 |
|
|
2022
Q4 | $2.49M | Buy |
99,776
+83,494
| +513% | +$2.08M | 0.01% | 1168 |
|
|
2022
Q3 | $354K | Sell |
16,282
-24,010
| -60% | -$522K | ﹤0.01% | 2697 |
|
|
2022
Q2 | $793K | Buy |
40,292
+26,275
| +187% | +$517K | ﹤0.01% | 2273 |
|
|
2022
Q1 | $593K | Buy |
+14,017
| New | +$593K | 0.01% | 2402 |
|
|
2021
Q4 | – | Sell |
-24,962
| Closed | -$1.47M | – | 3546 |
|
|
2021
Q3 | $1.47M | Buy |
24,962
+10,883
| +77% | +$639K | 0.02% | 1244 |
|
|
2021
Q2 | $683K | Sell |
14,079
-10,838
| -43% | -$526K | 0.01% | 1806 |
|
|
2021
Q1 | $968K | Buy |
+24,917
| New | +$968K | 0.01% | 1562 |
|